MicroGEM Revenue and Competitors

Location

$56.5M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • MicroGEM's estimated annual revenue is currently $3.5M per year.(i)
  • MicroGEM's estimated revenue per employee is $77,500
  • MicroGEM's total funding is $56.5M.

Employee Data

  • MicroGEM has 45 Employees.(i)
  • MicroGEM grew their employee count by -52% last year.

MicroGEM's People

NameTitleEmail/Phone
1
CEOReveal Email/Phone
2
Director Channel SalesReveal Email/Phone
3
Senior Director Assay Integration and ValidationReveal Email/Phone
4
Chief Financial OfficerReveal Email/Phone
5
Director - Plant SpecialistReveal Email/Phone
6
Chief Commercial OfficerReveal Email/Phone
7
Director Program ManagementReveal Email/Phone
8
Chief Technology OfficerReveal Email/Phone
9
Manager Product DevelopmentReveal Email/Phone
10
Group Financial ControllerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$4.3M284%N/AN/A
#3
$1.1M70%N/AN/A
#4
$3.5M45-52%$56.5MN/A
#5
$0.3M20%N/AN/A
#6
$4.5M2921%N/AN/A
#7
$1.9M129%N/AN/A
#8
$7M455%N/AN/A
#9
$6.7M435%N/AN/A
#10
$2M13-13%N/AN/A
Add Company

What Is MicroGEM?

MicroGEM serves to democratize molecular biology by moving molecular techniques out of conventional, highly skilled laboratories to non-laboratory settings where they can be used at point-of-need to solve complex biological problems. The company's innovative enzymatic approach to nucleic acid extraction provides the foundation for rapid sample preparation suitable for PCR analysis. Coupled with MicroGEM's expertise in microfluidics and synthetic biology, the company is strongly positioned to create person-portable diagnostic devices, representing the next generation of rapid, point-of-need solutions to address global health concerns.

keywords:N/A

$56.5M

Total Funding

45

Number of Employees

$3.5M

Revenue (est)

-52%

Employee Growth %

N/A

Valuation

N/A

Accelerator

MicroGEM News

2022-04-17 - New saliva COVID-19 test receives Emergency Use ...

MicroGEM, a Virginia-based molecular biology company with a Charlottesville office, is using its new saliva test to track COVID-19.

2022-04-17 - MICROGEM GRANTED EMERGENCY USE AUTHORIZATION ...

MicroGEM democratizes molecular biology by moving complex molecular biology tools out of highly skilled laboratories to non-laboratory settings...

2022-04-17 - US FDA grants EUA for MicroGEM's SARS-CoV-2 Saliva Test

Credit: MicroGEM / PRNewswire. The US Food and Drug Administration (FDA) has granted emergency use authorization (EUA) for...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
N/A4610%N/A
#2
$6.6M4618%N/A
#3
$9.9M465%N/A
#4
$3.7M4610%N/A
#5
$6.6M4610%N/A